Across TCGA pan-cancer cohorts, KLHL24 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated KLHL24 data layer compared with 22 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher KLHL24 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated KLHL24 expression acts as an unfavorable survival marker, although some lineages such as GBM and LSCC show a favorable association.
LUAD, HNSC, and GBM are the cancer types where KLHL24 mass-spec protein most reproducibly stratifies survival.